Induction and nosocomial dissemination of carbapenem and polymyxin-resistant Klebsiella pneumoniae

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 48, Issue 4, 2015, Pages 483-487

  Gaspar, Gilberto Gambero ^a   Bellissimo Rodrigues, Fernando ^a   de Andrade, Leonardo Neves ^a   Darini, Ana Lúcia ^a   Martinez, Roberto ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Colistin; Klebsiella pneumoniae; KPC; Polymyxin B

Indexed keywords

AMPHOTERICIN; CARBAPENEM; CARBAPENEMASE; CLINDAMYCIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; LEVOFLOXACIN; LINEZOLIDE; MEROPENEM; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN; POLYMYXIN B; TIGECYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN; VORICONAZOLE; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOMATED MICROBIAL IDENTIFICATION SYSTEM; BACTERIAL COLONIZATION; BACTERIAL ISOLATION; BACTERIAL TRANSMISSION; BONE MARROW TRANSPLANTATION; CASE REPORT; DEATH; FEMALE; HOSPITAL INFECTION; HUMAN; HYPOPITUITARISM; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LABORATORY DEVICE; MALE; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; NEUTROPENIA; NONHUMAN; SEPTIC SHOCK; ANTIBIOTIC RESISTANCE; CROSS INFECTION; DRUG EFFECTS; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

KLEBSIELLA PNEUMONIAE;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CARBAPENEMS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POLYMYXINS;

EID: 84940374693     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/0037-8682-0041-2015     Document Type: Article

References (15)

1. Braykov B, Eber MR, Klein EY, Morgan DJ, Laxminarayan R. Trend resistance to carbapenens and third generation cephalosporins among clinical isolates of K. pneumoniae in the United States, 1999-2010. Infect Control Hosp Epidemiol 2013; 34:259-268.
2. Cabral AB, Melo RC, Maciel MA, Lopes AC. Multidrug resistance genes, including bla (KPC) and bla (CTX-M-2), among Klebsiella pneumoniae isolated in Recife, Brazil. Rev Soc Bras Med Trop 2012; 45:572-578.
3. Rapp RP, Urban C. K. pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns. Pharmacotherapy 2012; 32:399-407.
4. Falagas ME, Rafailids PI, Ioannidou E, Aleixou VG, Mattraiou DK, Karageorpoulos DE, et al. Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a restrospective cohor study of 258 patients. Int J Antimicrob Agents 2010; 35:194-199.
5. Marchain D, Chopra T, Poque RM, Perez F, Huyer AM, Rudin S, et al. Outbreak of colistin-resistant, carbapenem-resistant, K. pneumoniae in metropolitan Detroit, Michingan. Antimicrob Ag Chemother 2011; 55:593-599.
6. The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoints tables for interpretation of MICs and zone diameters. Version 3.1. EUCAST; 2013. (Cited 2015 February). Available at http://www.eucast.org
7. Lat A, Clock SA, Wu F, Whittier S, Della-Latta P, Fauntleroy K, et al. Comparison of polimyxin B, tigecycline, cefepime and meropenem MICs for KPC-producing K. pneumoniae by broth microdilution, Vitek 2, and Etest. J Clin Microbiol 2011; 49: 1795-1798.
8. Andrade LN, Vitali L, Gaspar GG, Bellíssimo-Rodrigues F, Martinez R, Darini AL. Expansion and evolution of a virulent, extensively drug-resistant (polymyxin B-resistant), QnrS1-, CTX-M-2-, and KPC-2-producing Klebsiella pneumoniae ST11 international high-risk clone. J Clin Microbiol 2014; 52:2530-2535.
9. Minarini LAR, Clímaco EC, Guimarães DB, Ferreira JC, Palazzo ICV, Martinez R, et al. Clonal transmission of ESBL-producing Klebsiella spp at a university hospital in Brazil. Curr Microbiol 2008; 56:587-591.
10. Andrade LN, Curiao T, Ferreira JC, Longo J, Clímaco EC, Martinez R, et al. Dissemination of bla KPC-2 by the spread of K. pneumoniae clonal complex 258 clones plasmids (Inc F II, Inc L/M) among Entrerobacteriaceae species in Brazil. Antimicrob Ag Chemother 2011; 55:3579-3583.
11. Pereira PS, Araujo CF, Seki LM, Zahuer V, Carvalho-Assef AP, Asensi MD. Update of the molecular epidemiology of KPC-2-producing K. pneumoniae in Brazil: spread of clonal complex 11 (ST 11, ST 437 and ST 340). J Antimicrob Chemother 2013; 68:312-316.
12. Matthaiou DK, Michalopoulos A, Rafailidis PI, Karageorgopoulos DE, Papaionnou V, Nemi G, et al. Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study. Crit Case Med 2008; 36:807-811.
13. Halaby T, Al Naiemi N, Kluytmans J, van der Palen J, Vandenbroucke-Grauls CM. Emergence of colistin resistance in Enterobacteriaceae after the introduction of selective digestive tract decontamination in an intensive care unit. Antimicrob Ag Chemother 2013; 57:3224-3229.
14. Poudyal A, Howden BP, Bell JM, Gao W, Owen RJ, Turnidge JD, et al. In vitro pharmacodynamics of colistin against multidrugresistant K. pneumoniae. J Antimicrob Chemother 2008; 62: 1311-1318.
15. Capone A, Giannella M, Fortini D, Giordano A, Meledandu M, Ballardini M, et al. High rate of colistin resistance among patients with carbapenem-resistant K. pneumoniae infection accounts for an excess of mortality. Clin Microbiol Infect 2013; 19:e-23-e30.